Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.

In this month’s episode, we dive into some recent executive appointments occurring in the healthcare world, as well as layoffs affecting the industry. We also hear from Leslie Orne, who recently became the new CEO of Trinity Life Sciences, which provides consulting services and technology solutions to life sciences firms looking to commercialize their product.

The Consulate General of Canada in Chicago is currently celebrating the 75th anniversary of its diplomatic presence in the Midwest.

The Covid-19 pandemic has forced life sciences companies to take a fresh look at how they do business. But as they reinvent their operations, companies often overlook a critical function: Their learning and development programs.

Improving Customer Experience and Conversion in Healthcare & Life Sciences.

Leaders in healthcare draw attention to the myriad ways cloud computing technology is transforming healthcare.

Leaders in healthcare draw attention to the myriad ways cloud computing technology is transforming healthcare.

Faculty Opinions brings together the comments and opinions of thousands of top researchers in life sciences and medicine. Combined with H1’s extensive intel on healthcare providers, the acquisition expands H1’s reach and opportunity to impact healthcare by bringing this data under one umbrella, H1 CEO Ariel Katz said.

The life sciences industry is more quickly adapting to new methods, standards and requirements. The focus is now on how to drive greater data governance and quality through a unified framework.  The challenge comes in instituting a framework that will meet regulatory and labeling requirements.

The EHR giant is planning to buy Kantar Health, which provides data, analytics and research to the life sciences industry. Through the acquisition, Cerner aims to provide its clients with more access to data analytics and research expertise and engagement with life sciences companies.

The survey, conducted by Optum, shows that healthcare executives’ confidence in AI is high, and most expect to soon see cost savings from implementing the technology. Further, a majority are looking to hire talent with experience developing AI.

Did you miss the webinar? Register now and hear the best practices and new perspectives to help re-engage with your customers during the coronavirus pandemic.

In an interview, Peter Meath, J.P. Morgan’s co-head of Healthcare and Life Sciences, Middle Market Banking & Specialized Industries, says the Covid-19 pandemic has cast a bright light on the life sciences industry with startups raising venture funding at record levels as the virus has transformed the way people usually do business in the sector. 

The VC firm, started by the former heads of Foundation Medicine and Google Ventures, is raising $350 million for its third fund, according to a filing with the Securities and Exchange Commission.  

The healthcare investment management firm is working with the city’s nonprofit economic development corporation and Chicago-based MATTER on the new project, which will focus on life sciences and digital health.

Under the deal, which awaits city council approval, illustrates Seattle’s rapid growth as a life sciences hub, in addition to its larger IT sector. The nearly 3-acre parcel sits in a rapidly growing neighborhood that is also home to Amazon.

While it trails its U.S. counterpart, Europe’s life science sector has seen an increase in interest from investors lately. A report released Thursday by Silicon Valley Bank indicates growing investment in European biopharma and diagnostics.

Peer review is important for ensuring transparency and trust and may have put a stop to Theranos before it became a darling of investors and the press, the lead study author said in an interview.

The report, by law firm WSGR, noted an almost twofold increase in life sciences IPOs – especially biotech – and a greater number priced at $250 million or more.

A number of scenarios could indeed diminish the UK’s attractiveness, but it is likely to remain an important player, with a lot riding on the future regulatory regime.

Deals worth $50 million or more are becoming more frequent, even in Series A. But a VC investor said underlying drivers in life sciences are different from the technology sector.

With $320 million on hand to invest in life sciences startups, Westlake Village BioPartners will tap its founders’ biotechnology expertise.

The company’s life sciences track-and-trace network reaches drugmakers, pharmacies and others, with a customer base of more than 930 companies.

McDermott Will & Emery partner Kristian Werling is co-chair of the firm’s robust Life Sciences […]

These transactions best exemplify the most significant trends in the life sciences and biotech space.

One year ago, in collaboration with Lake Whillans and our sister site MedCity News, we […]

Cimphoni is expanding its reach with the addition of its Life Sciences division, which is focusing on treatment of osteoporosis, accelerated fracture healing and the diagnosis of periprosthetic joint infections.

The life sciences — particularly in biotechnology and pharmaceuticals — are among the very few […]